Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Teva Pharmaceutical Set for Major Layoffs in Israel, U.S.: Report
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
Sanofi buys into Teva's anti-TL1A therapy for IBD | pharmaphorum
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva drops migraine-drug patent case against Eli Lilly | Nasdaq
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva divesting $1 billion in assets to clear Allergan deal
Teva Pharmaceutical Industries – The Forward
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Jury finds Teva fueled opioid addiction in New York - YouTube
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
What's 'down' with Teva? - Israel News - The Jerusalem Post
GSK's $235 million verdict revived against Teva, again | Reuters
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva stock gains as company rules out impact from Israel war | Seeking Alpha
